Egyptian Drug Authority · Egypt
DEA-EG-2022-0004
Tier 1 · Regulator-publishedUnclassifiedRecallStatus · active
- Issuing authority
- Egyptian Drug Authority (EDA)
- Authority reference
- Periodic report no.(4) For 2022
- Date issued
- 21 Mar 2022
- Recorded by us
- 2026-09-06 19:45:29 UTC
- Product
- Gentaderm 1 mg/gm topical cream
- INN / active substance
- Not stated by the issuing authority
- Dosage form
- Not stated by the issuing authority
- Strength
- Not stated by the issuing authority
- Manufacturer
- Not stated by the issuing authority
- Manufacturer country
- Not stated by the issuing authority
- MAH or importer
- Not stated by the issuing authority
- Batch numbers
- 6061043
- Expiry dates
- Not published with the notice
- Action type
- Recall
- Classification
- Not stated by the issuing authority
- Indicative severity
- Not assessed by Drug Eye Africa
- Defect category
- Not stated by the issuing authority
- Product type
- Not stated by the issuing authority
- ATC code
- Not stated by the issuing authority
- Affected markets
- Egypt — no market beyond the issuing country was named on the notice
- Cross-border event
- Not linked to a cross-border event
- Notice text
- @egyptiandrugauthority
www.edaegypt.gov.eg
15301
١٢ مارس ٢٢٠٢
وذلك لكون المســـتحضر صادر له عدم مطابقة نهائية من معامل
هيئة الدواء المصرية
Gentaderm 1 mg/gm topical cream
6061043رقم التشغيلة
الشركة المالكة والمصنعة للمستحضر:الفرعونية للأدوية ) فارو فارما (
يتم ضبط وتحريز العبوات من المستحضر التالي:
منشور
سحب وتحريز
غير مطابق
GentadermOriginal language: ar
- Notice text in English
- Recall and seizure circular, non-conforming. The packs of the following product are to be impounded and seized: Gentaderm 1 mg/gm topical cream, batch number 6061043. The company owning and manufacturing the product is Pharaonia Pharmaceuticals (Pharo Pharma). A final finding of non-conformity has been issued for the product by the laboratories of the Egyptian Drug Authority. Dated 21 March 2022.Machine translation, produced by Drug Eye Africa and not checked by the issuing authority. The authority stated only the text above it.
- Status
- Active
- Superseded by
- Not superseded. This is the current version.
- Version
- 1
Where this record came from, and what is held to show it.
- Primary source
- https://www.edaegypt.gov.eg/media/fqncvfp5/%D9%85%D9%86%D8%B4%D9%88%D8%B1-4-%D9%84%D8%B3%D9%86%D8%A9-2022.pdf
- Copy of the source
- Taken and held by Drug Eye Africa, so the record survives the link above being moved or withdrawn. Not yet published at an address you can open.Ask us for it and check it against the fingerprint below.
- Fingerprint
- f64099cc5a75456f7cd22d2c1c006220f925da8469a4634a5f3978bb5412b015SHA-256 of the copy held. Any file that produces this number is that copy, byte for byte; any file that does not is a different document.
- Copy taken
- 2026-09-06 20:35:30 UTC
Cite this record
Drug Eye Africa (2022). DEA-EG-2022-0004: Gentaderm 1 mg/gm topical cream — Recall, Egyptian Drug Authority. Register of African Regulatory Actions. https://drugeyeafrica.org/register/notice/eg/2022/dea-eg-2022-0004Version history
—No version history recorded for this record.
—Corrections appear here and in the site-wide log. Records are superseded, never deleted.
Verification
Tier 1 — Published by the issuing regulator on its own channel and captured by Drug Eye Africa, with the source document archived.
Indexing
This record is indexable: it is dated, names a product, and carries either a batch number or a stated reason.